Echocardiographic findings of myeloblastoma in the heart

Sakai, Kichiro; Ando, Hiroshi; Nakamura, Kenji; Hosoda, Saichi

doi:10.1016/0002-8703(94)90691-2

Cited by 4 publications

(2 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Echocardiography can show an intracavitary, intramural, intrapericardial, or paracardial mass depending on the location of the tumor involvement. 7,15,16 However, echocardiography has an inherent limitation for differentiating granulocytic sarcoma from other types of cardiac tumors or even thrombus. Typically, cross-sectional imaging studies such as CT or magnetic resonance imaging are subsequently obtained for the confirmation and further characterization of the intracardiac mass detected initially on echocardiography.…”

Section: Discussionmentioning

confidence: 99%

MDCT Imaging Findings of Extramedullary Granulocytic Sarcoma of the Heart

Tsai

Lee

2010

Journal of Thoracic Imaging

View full text Add to dashboard Cite

Granulocytic sarcoma, also known as chloroma, is an uncommon tumor typically seen in patients with acute myelogenous leukemia (AML). Extramedullary cardiac involvement of granulocytic sarcoma is rare and there is a paucity of information regarding its multidetector computed tomography (MDCT) imaging appearance. We present a case of extramedullary granulocytic sarcoma of the heart detected on MDCT in a young adult male with AML. An understanding of how extramedullary granulocytic sarcoma of the heart appears on MDCT may decrease or prevent delays in diagnosing this uncommon, although important, complication from AML.

show abstract

Section: Discussionmentioning

confidence: 99%

MDCT Imaging Findings of Extramedullary Granulocytic Sarcoma of the Heart

Tsai

Lee

2010

Journal of Thoracic Imaging

View full text Add to dashboard Cite

show abstract

“…Only articles with adequate information about clinical presentation, diagnosis, therapy, and follow‐up were included in this study. By these criteria, the combination of the key words “chloroma,” “granulocytic sarcoma,” “myelosarcoma,” or “extramedullary myeloid cell tumor” with “child” or “pediatric” (paediatric) and review of the relevant references identified 45 patients in 39 publications 7,18–56. Patients with EMT who progressed to AML within 30 days after diagnosis to AML, as reported in 52 papers, did not fulfill the criteria for pEMT of Byrd et al 4 and were excluded.…”

Section: Methodsmentioning

confidence: 99%

Precursor B lymphoblastic leukemia 32 months after local therapy for a primary extramedullary myeloid cell tumor

Szinnai

Cogliatti

Avoledo

et al. 2006

Pediatric Blood & Cancer

View full text Add to dashboard Cite

A primary extramedullary myeloid cell tumor (pEMT) of an inguinal lymph node was completely excised without subsequent anti-tumor therapy in a 6-year-old child. Clinical observation and monitoring of blood and bone marrow (BM) did not reveal any pathologic results before 32 months, when a precursor B lymphoblastic leukemia was diagnosed. Identical T-cell receptor gamma rearrangement in nodal pEMT and in precursor B lymphoblastic leukemia in BM indicates a clonal relationship of these two tumors.

show abstract